An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Endemic Regions of Brazil
Sponsor: Evandro Chagas Research Institute, Bio-Manguinhos Technology and Immunology Institute
Terminated
This trial was terminated. No reason was provided.
This NA trial investigates Dengue and is currently terminated or withdrawn. Evandro Chagas Research Institute, Bio-Manguinhos Technology and Immunology Institute leads this study, which shows 12 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Mar 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Mar 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
May 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 7 earlier versions
-
Apr 2020 — May 2020 [monthly]
Terminated NA
Status: Completed → Terminated
-
Jun 2019 — Apr 2020 [monthly]
Completed NA
-
Mar 2019 — Jun 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2017 — Mar 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Evandro Chagas Research Institute, Bio-Manguinhos Technology and Immunology Institute
- GlaxoSmithKline
- Goncalo Moniz Research Center
- Tropical Disease Foundation
For direct contact, visit the study record on ClinicalTrials.gov .